Prostate cancer is common in men, but advanced cases can be tough to treat. Our doctors use radioligand therapy with Lutetium-177 to target and kill prostate cancer cells. While not a cure, it improves quality of life and offers more time. This success shapes the future of advanced prostate cancer treatment. Subscribe for more health insights from Mayo Clinic. #prostatecancertreatment #RadioligandTherapy #CancerTreatment #MayoClinic #HealthTips Learn more: https://mayocl.in/3KhehFf From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi Visit Mayo Clinic: https://mayocl.in/2COVmlm Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic